Epitomee Medical Ltd (EPIT.TA)

ILA 1060.0

(2.42%)

Market Cap (In ILA)

315.9 Million

Revenue (In ILA)

10 Million

Net Income (In ILA)

-5.68 Million

Avg. Volume

258.74 Thousand

Currency
ILA
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
249.4-1570.0
PE
-
EPS
-
Beta Value
0.837
ISIN
IL0011825911
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Dr. Radan Hashimshony Ph.D.
Employee Count
-
Website
https://www.epitomeemedical.com
Ipo Date
2021-12-15
Details
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide. Its capsule is used for weight management, waist circumference reduction, and cardiovascular risk factors reduction. Epitomee Medical Ltd has a strategic partnership with Nestlé Health Science S.A. for the development and commercialization of the weight loss capsule. The company was incorporated in 2005 and is based in Caesarea, Israel.